Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06609148 · ClinicalTrials.gov registry record · NA
Probiotic in Patients With Bile Acid Malabsorption/Diarrhea
A NA study of Bile Acid Malabsorption and Bile Acid Diarrhea, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06609148 is a NA study of Bile Acid Malabsorption and Bile Acid Diarrhea that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06609148, a NA study of Bile Acid Malabsorption and Bile Acid Diarrhea, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess effect of the DSF probiotic on fecal bile acid levels in patients with BAM.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT De Simone formulation probiotic
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-01-02 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06609148
The ClinicalTrials.gov registry entry for NCT06609148 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bile Acid Malabsorption appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06609148 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06609148 about?
NCT06609148 is a clinical study titled "Probiotic in Patients With Bile Acid Malabsorption/Diarrhea". The purpose of this study is to assess effect of the DSF probiotic on fecal bile acid levels in patients with BAM.
What is the current status of trial NCT06609148?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-01-02. Estimated completion is 2026-03-30.
What conditions does trial NCT06609148 study?
This clinical trial studies the following conditions: Bile Acid Malabsorption, Bile Acid Diarrhea.
What interventions are being tested in trial NCT06609148?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), De Simone formulation probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06609148?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06609148 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.